Overview

A Study in Subjects With Perennial Allergic Rhinitis

Status:
Completed
Trial end date:
2003-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine the efficacy and safety of the study drug compared to placebo for the treatment of subjects with perennial allergic rhinitis.
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.